share_log

Arovella Therapeutics Ltd: Arovella licenses novel CAR-iNKT cell armouring technology

Jan 30 06:57
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.